$ACT

Genworth Holdings, Inc. sold $34.0M of ACT

Genworth Holdings, Inc. sold 687,379 shares of Enact Holdings, Inc. (ACT) at $49.40 ($33.95M total) on 2026-08-31.

Original reporting
SEC EDGAR · Genworth Holdings, Inc.
Published Sep 1, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACT
Bearish
medium confidence
Mentioned
$ACT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACTBearishMed
01

Why it matters

The disclosure provides fresh, material information about insider activity, which can influence short‑term trading decisions.

02

Market read

New insider sale of over $30M may affect ACT's stock price and sentiment among investors.

03

What to watch

Genworth's own liquidity needs or tax planning may drive the transaction, not ACT fundamentals.

Relevance 7/10Novelty 7/10Timing: post-market today

Background

Form 4 filing by Genworth, a 10% owner of Enact Holdings, disclosing an open‑market sale of 687,379 shares.

Company-level read

Ticker impact

$ACTBearishMedium confidence
Context

Genworth sold 687,379 shares of Enact Holdings for $33.95M on 2026-08-31.

Expected impact

possible short-term downside of 2-4% as market digests the sale.

Evidence & confidence

10% owner sold a sizable block via open market, indicating possible liquidity need or valuation concerns.

Market effects

Insider sale may raise questions about the broader health of the insurance and reinsurance sector.

Limited to U.S. markets where ACT trades.

Minimal global impact beyond investors tracking ACT.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Genworth Holdings, Inc.

    10% owner of Enact Holdings reporting the sale.

  • Enact Holdings, Inc.

    Issuer of the shares sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACTMedAI 8/10

Enact (ACT) Q2 2026 Earnings Call Transcript

Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.